51 | 17074894 | The NapF protein of the Escherichia coli periplasmic nitrate reductase system: demonstration of a cytoplasmic location and interaction with the catalytic subunit, NapA. | Microbiology (Reading) | 2006 Nov |
1 |
52 | 17161819 | Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. | Int Immunopharmacol | 2007 Jan |
4 |
53 | 17924112 | Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study. | Rheumatol Int | 2008 Mar |
1 |
54 | 18173918 | Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes. | Clin Exp Rheumatol | 2007 Nov-Dec |
2 |
55 | 18953652 | Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells. | Breast Cancer Res Treat | 2009 Nov |
6 |
56 | 19127062 | Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. | Dev Neurosci | 2008 |
2 |
57 | 19414384 | Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells. | Anticancer Res | 2009 Apr |
3 |
58 | 20113495 | A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes. | Arthritis Res Ther | 2010 |
10 |
59 | 21903092 | Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation. | Biochem Pharmacol | 2011 Dec 1 |
17 |
60 | 21945668 | Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression. | Biochem Pharmacol | 2011 Dec 15 |
3 |
61 | 24418856 | TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels. | Am J Surg Pathol | 2014 Feb |
1 |
62 | 27836674 | Chondroprotective activity of N-acetyl phenylalanine glucosamine derivative on knee joint structure and inflammation in a murine model of osteoarthritis. | Osteoarthritis Cartilage | 2017 Apr |
6 |
63 | 28154142 | Dissecting the proton transport pathway in electrogenic Na<sup>+</sup>/H<sup>+</sup> antiporters. | Proc Natl Acad Sci U S A | 2017 Feb 14 |
1 |
64 | 29147265 | CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line. | World J Oncol | 2011 Dec |
1 |
65 | 29965477 | [Start-Up and Regional Characteristics of a Pilot-scale Integrated PN-ANAMMOX Reactor]. | Huan Jing Ke Xue | 2018 Mar 8 |
1 |
66 | 30845766 | Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and <i>N</i>-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats. | Pharmaceutics | 2019 Mar 6 |
6 |
67 | 31461854 | <i>E. coli</i> Enterotoxin LtB Enhances Vaccine-Induced Anti-<i>H. pylori</i> Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions. | Cells | 2019 Aug 27 |
1 |
68 | 34363898 | The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. | Immunol Lett | 2021 Nov |
1 |
69 | 34452094 | Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach. | Pharmaceutics | 2021 Jul 25 |
1 |
70 | 34617854 | Procainamide pharmacokinetics during extracorporeal membrane oxygenation. | Perfusion | 2021 Oct 7 |
1 |